▶ 調査レポート

コレラワクチンのアメリカ市場2017

• 英文タイトル:United States Cholera Vaccine Market Report 2017

QYResearchが調査・発行した産業分析レポートです。コレラワクチンのアメリカ市場2017 / United States Cholera Vaccine Market Report 2017 / A042104698資料のイメージです。• レポートコード:A042104698
• 出版社/出版日:QYResearch / 2017年3月1日
• レポート形態:英文、PDF、102ページ
• 納品方法:Eメール(受注後2~3営業日)
• 産業分類:医療・製薬・バイオ
• 販売価格(消費税別)
  Single User¥418,000 (USD3,800)▷ お問い合わせ
  Enterprise¥836,000 (USD7,600)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、コレラワクチンのアメリカ市場について調査・分析し、コレラワクチンのアメリカ市場概観、コレラワクチンの種類別市場分析、用途別市場分析、コレラワクチンのアメリカ市場規模予測、関連企業分析、関連企業情報、価格情報、販売動向、アメリカ市場動向、貿易動向、市場環境分析情報などを含め、以下の構成でお届けいたします。

・コレラワクチンのアメリカ市場概観
・コレラワクチンの種類別市場規模
・コレラワクチンの用途別市場規模
・コレラワクチンのアメリカ市場規模
・コレラワクチンのアメリカ市場予測
・コレラワクチンの製造メーカー分析
・コレラワクチンのメーカー別生産量
・コレラワクチンのメーカー別市場シェア
・コレラワクチンの価格動向・価格分析
・コレラワクチンの販売(売上高)動向
・コレラワクチンの貿易(輸出・輸入)動向
・コレラワクチンの産業チェーン分析
・コレラワクチンのマーケティング戦略分析
・コレラワクチンの販売業者(代理店)リスト
・コレラワクチンの市場環境分析
...

Notes:Sales, means the sales volume of Cholera Vaccine
Revenue, means the sales value of Cholera Vaccine

This report studies sales (consumption) of Cholera Vaccine in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
BiondVax Pharmaceuticals
Bharat Biotech International Limited
GlaxoSmithKline
Hualan Biological Engineering
Janssen Pharmaceuticals
MedImmune
Merck
Pfizer
Sanofi Pasteur SA

Market Segment by States, covering
California
Texas
New York
Florida
Illinois
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
Type I
Type II
Split by applications, this report focuses on sales, market share and growth rate of Cholera Vaccine in each application, can be divided into
Application 1
Application 2

レポート目次

Table of Contents

United States Cholera Vaccine Market Report 2017
1 Cholera Vaccine Overview
1.1 Product Overview and Scope of Cholera Vaccine
1.2 Classification of Cholera Vaccine
1.2.1 Type I
1.2.2 Type II
1.3 Application of Cholera Vaccine
1.3.1 Application 1
1.3.2 Application 2
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Cholera Vaccine (2012-2022)
1.4.1 United States Cholera Vaccine Sales and Growth Rate (2012-2022)
1.4.2 United States Cholera Vaccine Revenue and Growth Rate (2012-2022)

2 United States Cholera Vaccine Competition by Manufacturers
2.1 United States Cholera Vaccine Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Cholera Vaccine Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Cholera Vaccine Average Price by Manufactures (2015 and 2016)
2.4 Cholera Vaccine Market Competitive Situation and Trends
2.4.1 Cholera Vaccine Market Concentration Rate
2.4.2 Cholera Vaccine Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion

3 United States Cholera Vaccine Sales (Volume) and Revenue (Value) by States (2012-2017)
3.1 United States Cholera Vaccine Sales and Market Share by States (2012-2017)
3.2 United States Cholera Vaccine Revenue and Market Share by States (2012-2017)
3.3 United States Cholera Vaccine Price by States (2012-2017)

4 United States Cholera Vaccine Sales (Volume) and Revenue (Value) by Type (2012-2017)
4.1 United States Cholera Vaccine Sales and Market Share by Type (2012-2017)
4.2 United States Cholera Vaccine Revenue and Market Share by Type (2012-2017)
4.3 United States Cholera Vaccine Price by Type (2012-2017)
4.4 United States Cholera Vaccine Sales Growth Rate by Type (2012-2017)

5 United States Cholera Vaccine Sales (Volume) by Application (2012-2017)
5.1 United States Cholera Vaccine Sales and Market Share by Application (2012-2017)
5.2 United States Cholera Vaccine Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 United States Cholera Vaccine Manufacturers Profiles/Analysis
6.1 BiondVax Pharmaceuticals
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Cholera Vaccine Product Type, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 BiondVax Pharmaceuticals Cholera Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Bharat Biotech International Limited
6.2.2 Cholera Vaccine Product Type, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Bharat Biotech International Limited Cholera Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 GlaxoSmithKline
6.3.2 Cholera Vaccine Product Type, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 GlaxoSmithKline Cholera Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Hualan Biological Engineering
6.4.2 Cholera Vaccine Product Type, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Hualan Biological Engineering Cholera Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Janssen Pharmaceuticals
6.5.2 Cholera Vaccine Product Type, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Janssen Pharmaceuticals Cholera Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 MedImmune
6.6.2 Cholera Vaccine Product Type, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 MedImmune Cholera Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Merck
6.7.2 Cholera Vaccine Product Type, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Merck Cholera Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Pfizer
6.8.2 Cholera Vaccine Product Type, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Pfizer Cholera Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Sanofi Pasteur SA
6.9.2 Cholera Vaccine Product Type, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Sanofi Pasteur SA Cholera Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview

7 Cholera Vaccine Manufacturing Cost Analysis
7.1 Cholera Vaccine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Cholera Vaccine

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Cholera Vaccine Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Cholera Vaccine Major Manufacturers in 2015
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Cholera Vaccine Market Forecast (2017-2022)
11.1 United States Cholera Vaccine Sales, Revenue Forecast (2017-2022)
11.2 United States Cholera Vaccine Sales Forecast by Type (2017-2022)
11.3 United States Cholera Vaccine Sales Forecast by Application (2017-2022)
11.4 Cholera Vaccine Price Forecast (2017-2022)

12 Research Findings and Conclusion

13 Appendix
Methodology
Analyst Introduction
Data Source

List of Tables and Figures

Figure Picture of Cholera Vaccine
Table Classification of Cholera Vaccine
Figure United States Sales Market Share of Cholera Vaccine by Type in 2015
Table Application of Cholera Vaccine
Figure United States Sales Market Share of Cholera Vaccine by Application in 2015
Figure United States Cholera Vaccine Sales and Growth Rate (2012-2022)
Figure United States Cholera Vaccine Revenue and Growth Rate (2012-2022)
Table United States Cholera Vaccine Sales of Key Manufacturers (2015 and 2016)
Table United States Cholera Vaccine Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Cholera Vaccine Sales Share by Manufacturers
Figure 2016 Cholera Vaccine Sales Share by Manufacturers
Table United States Cholera Vaccine Revenue by Manufacturers (2015 and 2016)
Table United States Cholera Vaccine Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Cholera Vaccine Revenue Share by Manufacturers
Table 2016 United States Cholera Vaccine Revenue Share by Manufacturers
Table United States Market Cholera Vaccine Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Cholera Vaccine Average Price of Key Manufacturers in 2015
Figure Cholera Vaccine Market Share of Top 3 Manufacturers
Figure Cholera Vaccine Market Share of Top 5 Manufacturers
Table United States Cholera Vaccine Sales by States (2012-2017)
Table United States Cholera Vaccine Sales Share by States (2012-2017)
Figure United States Cholera Vaccine Sales Market Share by States in 2015
Table United States Cholera Vaccine Revenue and Market Share by States (2012-2017)
Table United States Cholera Vaccine Revenue Share by States (2012-2017)
Figure Revenue Market Share of Cholera Vaccine by States (2012-2017)
Table United States Cholera Vaccine Price by States (2012-2017)
Table United States Cholera Vaccine Sales by Type (2012-2017)
Table United States Cholera Vaccine Sales Share by Type (2012-2017)
Figure United States Cholera Vaccine Sales Market Share by Type in 2015
Table United States Cholera Vaccine Revenue and Market Share by Type (2012-2017)
Table United States Cholera Vaccine Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Cholera Vaccine by Type (2012-2017)
Table United States Cholera Vaccine Price by Type (2012-2017)
Figure United States Cholera Vaccine Sales Growth Rate by Type (2012-2017)
Table United States Cholera Vaccine Sales by Application (2012-2017)
Table United States Cholera Vaccine Sales Market Share by Application (2012-2017)
Figure United States Cholera Vaccine Sales Market Share by Application in 2015
Table United States Cholera Vaccine Sales Growth Rate by Application (2012-2017)
Figure United States Cholera Vaccine Sales Growth Rate by Application (2012-2017)
Table BiondVax Pharmaceuticals Basic Information List
Table BiondVax Pharmaceuticals Cholera Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Figure BiondVax Pharmaceuticals Cholera Vaccine Sales Market Share (2012-2017)
Table Bharat Biotech International Limited Basic Information List
Table Bharat Biotech International Limited Cholera Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Table Bharat Biotech International Limited Cholera Vaccine Sales Market Share (2012-2017)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Cholera Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Table GlaxoSmithKline Cholera Vaccine Sales Market Share (2012-2017)
Table Hualan Biological Engineering Basic Information List
Table Hualan Biological Engineering Cholera Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Table Hualan Biological Engineering Cholera Vaccine Sales Market Share (2012-2017)
Table Janssen Pharmaceuticals Basic Information List
Table Janssen Pharmaceuticals Cholera Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Table Janssen Pharmaceuticals Cholera Vaccine Sales Market Share (2012-2017)
Table MedImmune Basic Information List
Table MedImmune Cholera Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Table MedImmune Cholera Vaccine Sales Market Share (2012-2017)
Table Merck Basic Information List
Table Merck Cholera Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Table Merck Cholera Vaccine Sales Market Share (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Cholera Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Table Pfizer Cholera Vaccine Sales Market Share (2012-2017)
Table Sanofi Pasteur SA Basic Information List
Table Sanofi Pasteur SA Cholera Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Table Sanofi Pasteur SA Cholera Vaccine Sales Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Cholera Vaccine
Figure Manufacturing Process Analysis of Cholera Vaccine
Figure Cholera Vaccine Industrial Chain Analysis
Table Raw Materials Sources of Cholera Vaccine Major Manufacturers in 2015
Table Major Buyers of Cholera Vaccine
Table Distributors/Traders List
Figure United States Cholera Vaccine Production and Growth Rate Forecast (2017-2022)
Figure United States Cholera Vaccine Revenue and Growth Rate Forecast (2017-2022)
Table United States Cholera Vaccine Production Forecast by Type (2017-2022)
Table United States Cholera Vaccine Consumption Forecast by Application (2017-2022)
Table United States Cholera Vaccine Sales Forecast by States (2017-2022)
Table United States Cholera Vaccine Sales Share Forecast by States (2017-2022)